Endothelium-dependent relaxation in resistance arteries from spontaneously hypertensive rats: Effect of long-term treatment with perindopril, quinapril, hydralazine or amlodipine

Journal of Hypertension

Volumn 14, Issue 3, 1996, Pages 389-397

  Bennett, Michael A ^a   Hillier, Christopher ^b   Thurston, Herbert ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Acetylcholine; Angiotensin converting enzyme inhibition; Antihypertensive therapy; Bradykinin; Endothelium dependent relaxation; Resistance arteries

Indexed keywords

ACETYLCHOLINE; AMLODIPINE; BRADYKININ; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; PERINDOPRIL; QUINAPRIL; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE THERAPY; ARTERY; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; HYPERTENSION; LONG TERM CARE; MESENTERIC ARTERY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RESISTANCE BLOOD VESSEL; SMOOTH MUSCLE RELAXATION; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

EID: 0029869932     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199603000-00017     Document Type: Article

References (39)

1. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980, 288:373-376.
2. Palmer RM, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987, 327:524-526.
3. Myers RR, Minor RL, Guerra R, Bates JN, Harrison DG: Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrocysteine than nitric oxide. Nature 1989, 365:161-163.
4. Mulsch A, Busse R: NG-nitro-L-arg (N5-[imino(nitroamino) methyl]-L-omithine) impairs endothelium dependent dilation by inhibiting cytosolic nitric oxide synthesis from L-arginine. Naunyn-Schmied Arch Pharmacol 1989, 341:143-147.
5. Bennett MA, Watt PAC, Thurston H: Endothelium-dependent modulation of resistance vessel contractility: studies with NG-nitro-L-arginine methyl ester and NG-nitro-L-arginine. Br J Pharmacol 1992, 107:616-621.
6. Gabbiani G, Elemer G, Guelpa C, Vallotton MD, Badonnel MC, Huttner I: Morphologic and functional changes of the aortic intima during experimental hypertension. Am J Pathol 1979, 96:399-422.
7. Konishi M, Su C: Role of endothelium in dilator responses of spontaneously hypertensive rat arteries. Hypertension 1983, 5:881-886.
8. Winiquist RJ, Bunting PB, Baskin EP, Wallace AA: Decreased endothelium-dependent relaxation in New Zealand genetically hypertensive rats. J Hypertens 1984, 2:541-545.
9. Luscher TF, Vanhoutte PM: Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension 1986, 8:344-348.
10. Watt PAC, Thurston H: Endothelium-dependent relaxation in resistance vessels from the spontaneously hypertensive rats. J Hypertens 1989, 7:661-666.
11. Li J, Bukoski RD: Endothelium-dependent relaxation of hypertensive resistance arteries is not impaired under all conditions. Circ Res 1993, 72:290-296.
12. Arvola P, Ruskoaho H, Wuorela H, Pekki A, Vapaatalo H, Porsti I: Quinapril treatment and arterial smooth muscle responses in spontaneously hypertensive rats. Br J Pharmacol 1993, 108:980-990.
13. Clozel M, Kuhn H, Hefti F: Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. Hypertension 1990, 16:532-540.
14. Schultz PJ, Raij L: Effects of antihypertensive agents on endothelium-dependent and endothelium-independent relaxations. Br J Clin Pharmacol 1989, 28:1513-1573.
15. Swales JD, Tange JD: Photo-electric method of blood pressure measurement in the rat. J Lab Clin Med 1970, 105:679-685.
16. Mulvany MJ, Halpern W: Mechanical properties of vascular smooth muscle cells in situ. Nature 1976, 260:617-619.
17. Luscher TF, Aarhus LL, Vanhoutte PM: Indomethacin improves the impaired endothelium-dependent relaxations in small mesenteric resistance arteries of the spontaneously hypertensive rat. Am J Physiol 1990, 3:55-58.
18. Shimamura K, Osugi S, Moriyama K, Sunano S: Impairment and protection of endothelium-dependent relaxation in aortae of various strains of spontaneously hypertensive rats. J Cardiovasc Pharmacol 1991, 17 (suppl 3): 133-136.
19. Rubanyi GM, Katusic K, Graser T: Effect of cilazapril and indomethacin on endothelial dysfunction in the aortas of spontaneously hypertensive rats. J Cardiovasc Pharmacol 1993, 22 (suppl 5):s23-s30.
20. Gray GG, Clozel M, Clozel J-P, Baumgartner H-R: Effects of calcium channel blockade on the intima in spontaneously hypertensive rats. Hypertension 1993, 22:569-576.
21. Tschudi MR, Criscione L, Novosel D, Pfeiffer K, Luscher TF: Antihypertensive therapy augments endothelium-dependent relaxations in coronary arteries of spontaneously hypertensive rats. Circulation 1994, 89:2212-2218.
22. Dohi Y, Criscione L Pfeiffer K, Luscher TF: Angiotensin blockade or calcium antagonists improve endothelial dysfunction in hypertension: studies in perfused mesenteric resistance arteries. J Cardiovasc Pharmacol 1994, 24:372-379.
23. Bossaller C, Auch-Welk W, Weber F, Gotze S, Grafe M, Graf K, et al.: Endothelium-dependent relaxations are augmented in rats chronically treated with the angiotensin-converting enzyme inhibitor enalapril. J Cardiovasc Pharmacol 1992, 20 (suppl 9):s91-s95.
24. Rizzoni D, Castellano M, Porteri E, Bettoni G, Muiesan ML, Cinelli A, et al.: Effects of low and high doses of fosinopril on the structure and function of resistance arteries. Hypertension 1995, 26:118-123.
25. 2 as an endothelium-derived contracting factor and its interaction with endothelium-derived nitric oxide. J Hypertens 1991, 9:729-736.
26. Kato T, Iwama Y, Okumura K, Hashimoto H, Ito T, Satake T: Prostaglandin H2 may be the contracting factor released by acetylcholine in the aorta of the rat. Hypertension 1990, 14:542-548.
27. Yang Z, Arnet U, von Segesser L, Siebenmann R, Turina M, Luscher TF: Different effects of angiotensin-converting enzyme inhibition in human arteries and veins. J Cardiovasc Pharmacol 1993, 22 (suppl 5):s17-s22.
28. Thomas GR, Walder CE, Thiemermann C, Vane JR: Regional and vascular resistance and haemodynamics in the spontaneously hypertensive rats. The effect of bradykinin. J Cardiovasc Pharmacol 1990, 15:211-217.
29. Richard V, Tanner FC, Tschudi M, Luscher TF: Different activation of L-arginine pathway by bradykinin, serotonin, and clonidine in coronary arteries. Am J Physiol 1990, 259:H1433-H1439.
30. G-nitro-L-arginine methyl ester. Br J Pharmacol 1990, 101:632-639.
31. Flavahan NA: Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/nitric oxide activity. Circulation 1992, 85:1927-1938.
32. Ljusengren ME, Axelsson KL, Ahlner J: Effects of pertussis toxin on vasodilation and cyclic GMP in bovine mesenteric arteries and demonstration of a 40 KDa soluble protein ribosylation substrate for pertussis toxin. Life Sci 1990, 46:543-552.
33. Cohen RA, Tesfamariam B: Diabetes mellitus and the endothelium. In: Hyperglycaemia, Diabetes and Vascular Disease. Edited by Rudderman N, Brownlee M, Williamson JJ. New York: Oxford University Press; 1992:48-58.
34. Taylor SJ, Chae HZ, Rhee SG, Exton JH: Activation of the beta 1 isoenzyme of phospholipase C by alpha subunits of the Gq class of G-proteins. Nature 1991, 350:516-518.
35. Shimokawa H, Flavahan NA, Vanhoutte PM: Loss of endothelial pertussis-toxin sensitive G-protein function in atherosclerotic porcine coronary arteries. Circulation 1991, 83:652-660.
36. Mombouli JV, Nephtali M, Vanhoutte PM: Effects of the converting enzyme inhibitor cilazaprilat on endothelium-dependent responses. Hypertension 1991, 18 (suppl II): 22-29.
37. Mombouli JV, Illiano S, Nagao T, Scott-Burden T, Vanhoutte PM: Potentiations of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors. Circ Res 1992, 71:137-144.
38. Beny J-L, Brunet P, Huggel H: Interaction of bradykinin and des-Arg9-bradykinin with isolated pig coronary arteries: Mechanical and electrophysiological events. Regul Peptides 1987, 17:181-190.
39. Yang HY, Erdos EG, Levin Y: A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin. Biochim Biophys Acta 1970, 214:374-376.